Metabolic dysfunction in the brain: implications of astrocyte activation
-
1
Pontificia Universidad Javeriana, Deparment of Nutrition and Biochemistry, Colombia
Astrocytes are the most abundant cells in the central nervous system (CNS). They participate in different processes such as maintaining the blood–brain barrier and ion homeostasis, uptake and turnover of neurotransmitters, and formation of synapses. In addition, astrocytes also respond to brain insults to prevent the damage. For instance, astrocyte activation plays a central role in the cellular response to brain insults like trauma, infections, stroke, tumorigenesis, and neurodegeneration. However, chronic astrocyte activation can also interfere with normal brain function. Neurodegenerative diseases like Alzheimer’s, Parkinson and amyotrophic lateral sclerosis are characterized by an inflammatory response that is considered the main cause of damage in these CNS disorders. This response is mediated by activated glial cells, which overexpress cytokines like TNF-a, IL-1β, IL-6, and other different pro-inflammatory factors. These pro-inflammatory signalling cascades can cause neurotoxicity and cell-death by reducing the astrocyte capacity of releasing neurotrophic factors, therefore decreasing their repair capability. Astrocyte activation is a dynamic process and its regulation is critical for maintaining an optimal neurological function that avoids the deleterious effects in neuronal survival. However, cellular and functional changes during astrocyte activation can be regulated in a context-specific manner by inter- and intracellular signalling molecules, for example increases in ammonium, glutamate, reactive oxygen species, and nitric oxide favoured astrocyte activation. In this review, we will discuss the state of the art of the metabolic changes that can lead to astrocyte activation and the possible therapeutic approaches to regulate these metabolic changes in astrocytes and their impact in neurons.
Acknowledgements
This work was supported by grant PUJ ID 5879.
References
Hamby, M. E., and Sofroniew, M. V. (2010). Reactive astrocytes as therapeutic targets for CNS disorders. Neurotherapeutics7, 494–506. doi: 10.1016/j.nurt.2010.07.003
Kang, W., and Hebert, J. M. (2011). Signaling pathways in reactive astrocytes, a genetic perspective. Mol. Neurobiol. 43, 147–154. doi: 10.1007/s12035-011-8163-7
Kimelberg, H. K., and Nedergaard, M. (2010). Functions of astrocytes and their potential as therapeutic targets.Neurotherapeutics 7, 338–353. doi: 10.1016/j.nurt.2010.07.006
Oberheim, N. A., Goldman, S. A., and Nedergaard, M. (2012). Heterogeneity of astrocytic form and function. Methods Mol. Biol. 814, 23–45. doi: 10.1007/978-1-61779-452-0_3
Volterra, A., and Meldolesi, J. (2005). Astrocytes, from brain glue to communication elements: the revolution continues.Nat. Rev. Neurosci. 6, 626–640. doi: 10.1038/nrn1722
Keywords:
neurodegenerative disease,
Inflammation,
Astrocyte activation,
excitotoxicity,
energetic failure.,
modulate astrocyte activation
Conference:
Latin-American School on glial cells in the diseased brain (IBRO), Bogotá, Colombia, 13 Jul - 17 Jul, 2015.
Presentation Type:
Poster Presentation
Topic:
Neural excitability, synaptic transmission, glia: Cellular and molecular mechanisms
Citation:
Albarracin
SL,
Sutachan
JJ,
Mayorquin
LC and
Gonzalez
J
(2015). Metabolic dysfunction in the brain: implications of astrocyte activation.
Conference Abstract:
Latin-American School on glial cells in the diseased brain (IBRO).
doi: 10.3389/conf.fncel.2015.35.00032
Copyright:
The abstracts in this collection have not been subject to any Frontiers peer review or checks, and are not endorsed by Frontiers.
They are made available through the Frontiers publishing platform as a service to conference organizers and presenters.
The copyright in the individual abstracts is owned by the author of each abstract or his/her employer unless otherwise stated.
Each abstract, as well as the collection of abstracts, are published under a Creative Commons CC-BY 4.0 (attribution) licence (https://creativecommons.org/licenses/by/4.0/) and may thus be reproduced, translated, adapted and be the subject of derivative works provided the authors and Frontiers are attributed.
For Frontiers’ terms and conditions please see https://www.frontiersin.org/legal/terms-and-conditions.
Received:
22 Feb 2015;
Published Online:
11 Jun 2015.
*
Correspondence:
Prof. Sonia L Albarracin, Pontificia Universidad Javeriana, Deparment of Nutrition and Biochemistry, Bogota, D.C., Colombia, albarra@javeriana.edu.co